OBIO CEO Gail Garland was asked by MDCC to provide opening remarks at their hotly anticipated Strategic Entry into the U.S. MedTech Market for Canadian Firms Seminar.

The Greater MSP and MDCC brought to Toronto 4 world-class experts with backgrounds in finance, reimbursement, talent management and the FDA.  Each shared their insights and tools for success for strategically entering into the U.S. MedTech market.

Demo Day is the culmination of The Hatchery’s intensive summer program, where student teams work with experienced mentors — including executives, lawyers, medical professionals and engineers — to develop their business ideas and competencies. They receive detailed feedback and guidance on everything from patent applications and incorporation to honing their pitches and building prototypes, which they create using 3D printers and other fabrication resources provided by The Hatchery.

The seed funding at stake at Demo Day includes a grand prize of $20,000 and a runner-up prize of $10,000, donated by alumnus Anthony Lacavera (CompE 9T7), founder and chairman of Globalive Holdings and former CEO of WIND Mobile. An additional $2,500 Orozco prize is provided through funds raised by the students themselves.

For the full article, click here

Former OBIO CAAP company Tecla is helping those who live with Multiple Sclerosis, learn about Michael's story today!

The prize was awarded for their contact lens which could completely change how diabetics monitor their blood sugar.

The lens non-invasively monitors glucose levels and transmits the information to a mobile phone, Harry Gandhi, co-founder of Medella Health, told CBC News. Medella Health won the national prize in the James Dyson Award, a world-renowned design competition with a top national prize of $4,000.

For the full CBC article click here

For the CTV News feature, click here

Sept 6, 2016 NERv Technologies was selected as one of the top 500 Deep Tech startups at the upcoming Hello Tomorrow Global Summit in Paris.

Follow their journey on twitter here

OBIO's Dr. Klaus Fiebig, CAAP Senior Director, Strategic Programs was asked to be a panelist on the Rotman School of Management - University of Toronto - Start-up & Entrepreneurs Panel.

Overall, there was a strong buzz in the room with many enthusiastic MBA students evaluating if entrepreneurship and the startup world would be the right fit in their very near future, we certainly hope so!

For a gallery of the event, please click here

Dawn joined TranQool because she felt that people need a platform where they can access counselling and services right at their fingertips.

TranQool enables you to talk with a real therapist in the comfort of your own home.  You sign up. are matched with a therapist, have one-on-one video calls and build on your progress with assignments.

For the interview click here

OBIO was invited to McMaster University by Susan Searls Giroux, Assistant Vice-President of McMaster University for a day filled with science, bus and partnerships.

The day started with a tour of the Biointerfaces Institute with the impressive John Brennan, Director of the Biointerfaces Institute. The discussion during the tour focused on diagnostics, cell therapies and biointerfaces and what the current and future needs will be for companies. 

Pre-CAAP company Akira MD has been prominently featured in Metro - one of the largest circulation daily papers in Ontario.

For the full article, click here

Pathcore Heading South to 43North!

OBIO Pre-CAAP Company Pathcore has made it to the 43North semi-finals in Buffalo this fall!

Every year 43North awards $5 MILLION in capital, including a grand prize of $1 Million,  to truly remarkable startups from around the world.

Learn more here

Aug 18, 2016 - Toronto-based ScarX Therapeutics (ScarX) has received approval from Health Canada to begin a Phase I clinical trial of its SCX-001 nefopam cream, a first-of-its-kind topical treatment developed to significantly reduce surgical scarring.

For the full press release click here

Jessica Ching, Co-Founder of Eve Medical won the Alumni Achievement Award. Eve Medical was selected for the 2014 "Next 36" class, and was honored for its achievements since graduating the intensive program.

For the full press release, click here

AUG 15, 2016 – VANCOUVER - The Top 10 finishers in the 2016 INTERFACE Health Challenge X have been selected. INTERFACE Health Challenge X is the world’s only annual competition to discover the world’s best digital health innovators.

This year's challenge started on March 1st at HiMSS 2016 in Las Vegas with this Call to discover the world's best digital health innovators.

OBIO CAAP Companies Medella Heath & Shift Health were among the finalists, as well as Pre-CAAP comapny NERv Technology. 

For the full article, click here

Former OBIO CAAP company MyndTec's MyndMove™ was highlighted on CTV News regarding brain-controlled robots helping paralyzed patients move again and the newly release study by Duke University, published in Nature.

MyndMove is already in use for upper body rehabilitation in parts of Canada.

"We have seen dramatic improvement in stroke and spinal cord patients,” said brainchild of MyndMove, Dr. Milos R. Popovic, the Toronto Rehab Institute Chair in Spinal Cord Injury Research and Professor in the Institute of Biomaterials and Biomedical Engineering at the University of Toronto.

For the video, click here

For the full text of the Duke study, click here

Congratulations to OBIO Pre-CAAP company iMerciv on being selected to compete at this years CNE Innovation Garage from August 19th - 21st (Enercare Centre at the CNE). 25 innovators from across the province will come together to compete in 5 categories for $25,000 Grand Prize!

The iMerciv BuzzClip is an assistive device that caters to the orientation & mobility needs of blind, deaf-blind and visually impaired communities around the globe. 

The Bio-tech Competition takes place: Friday August 19 @ 3pm. Remember to tweet and use the hashtag #cdntech

Learn more about the CNE Innovation Garage here

Stay Away from Me...I Am Sick

OBIO Pre-CAAP Company iamsick.ca knows that the last thing you want to do when you are sick is look for a family doctor, a walk-in-clinic or a nearby pharmacy.  The new app informs patients on what clinics are nearby (in your actual area) and pharmacies and to find out what clinics are accepting new patients (great when you move to a new area!) and book appointments online.

For the full article click here

Komodo's TECLA technology is making the wildly popular Pokemon GO game more accessible to wheelchair users and others with limited range of motion. 

For the full story and video, click here

Former OBIO CAAP company Eve Medical was highlighted on CBC News. The EVE Kit is gearing up to be ready for purchase online this fall!

"Canadian women may be able to self-administer tests for sexually transmitted infections from the comfort of their own homes, for less than $100." 

CEO Jessica Ching says, the hope is to make "it more convenient for women to test for HPV which could guard against cervical cancer."

Follow their progress and updates on Twitter @evemedical

For the CBC feature click here

Aug 8, 2016 - 4 OBIO Pre-CAAP companies have been selected as winners of the Ontario Brain Institute (OBI) 2016 ONtrepreneurs Program!

Congratulations to  Winterlight Labs, SensOR Medical Laboratory, TopSpin360 & iMerciv!

The ONtrepreneurs (Ontario Neurotech Entrepreneurs) Program helps "Ontario neurotech entrepreneurs take their ideas from the lab to the marketplace."

This year's winners participated in a pitching competition to a panel of "expert judges from organizations including Yocto Law, Biomedical Zone, Emmetros, AGE-WELL, Ironstone Product Development Inc. and OBI."

$300,000 ($50,000 each) has been awarded to the winners to assist with commercializing their neurotechnologies.

For the full press release, click here

AbCelex has been awarded a $3.4 million government investment to help develop a new line of anti-microbial feed additives to help control disease outbreaks in poultry flocks, Agriculture and Agri- Food Canada have reported.